Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Humabs BioMed S.A.
Description mAb which binds to 3 separate units at the base of the glycoprotein to interfere with the cleaving of a protein loop
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationEbola
Indication DetailsTreat Ebola virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today